Pharma News

Mentions of future of work decreased in the pharmaceutical industry in Q1 2023

Notably, future of work was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead of digitalization and cybersecurity, according to GlobalData.

Of the top leading companies in the pharmaceutical industry, Moderna had the greatest increase in references for future of work in Q1 2023, compared with the previous quarter. GlobalData identified 14 future of work-related sentences in the company’s filings – 0.5% of all sentences – and an increase of 100% in Q1 2023 compared with Q1 2022. Bayer’s mentions of future of work rose by 100% to 10 and ICON’s by 100% to 6 and Amgen’s by 100% to 5 and BioNTech’s by 100% to 5.

GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for future of work in Q1 2023 was 81.

For further understanding of GlobalData’s Future of Work – Thematic Research buy the report here.

Source link
#Mentions #future #work #decreased #pharmaceutical #industry

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *